Sleep apnea pill shows promise in small trial
NCT ID NCT05763329
First seen Nov 01, 2025 · Last updated Apr 28, 2026 · Updated 25 times
Summary
This study tested whether a single dose of the sleep drug lemborexant could improve breathing and sleep quality in 10 adults with moderate-to-severe obstructive sleep apnea (OSA) who have a low arousal threshold. Participants spent two nights in a sleep lab, receiving either the drug or a placebo, with a week between. The main goal was to see if lemborexant reduced the number of breathing pauses (AHI) and improved other sleep measures.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Chulalongkorn University
Pathum Wan, Bangkok, 10330, Thailand
Conditions
Explore the condition pages connected to this study.